TIGERQ AB

TIGERQ is a Cancer Genomics Software startup based in Lund, Sweden, founded in 2018. The company is focused on commercializing a patented and extremely accurate sequencing analysis for complex genetic changes that currently drive 73% of all cancers. This innovation is applicable to a substantial €2.8B cancer genomic software market. Their most recent investment was a €980.00K Seed Round led by SmiLe Venture Hub on 17 March 2021. TIGERQ's mission is underscored by their slogan: "TIGERQ is a Cancer Genomics Software startup commercializing the most accurate and comprehensive sequencing analysis." The company operates within the Analytics and Biotechnology industries, with a clear focus on addressing unmet needs in cancer genomics. By offering a groundbreaking approach to sequencing analysis, TIGERQ seeks to make a meaningful impact on the field of cancer research and treatment.